Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomics In Cancer Care Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Instruments
1.2.3 Consumables
1.2.4 Services
1.3 Market by Application
1.3.1 Global Genomics In Cancer Care Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Diagnostics
1.3.3 Personalized Medicine
1.3.4 Drug Discovery
1.3.5 Development
1.3.6 Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genomics In Cancer Care Market Perspective (2018-2033)
2.2 Genomics In Cancer Care Growth Trends by Region
2.2.1 Global Genomics In Cancer Care Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Genomics In Cancer Care Historic Market Size by Region (2018-2023)
2.2.3 Genomics In Cancer Care Forecasted Market Size by Region (2024-2033)
2.3 Genomics In Cancer Care Market Dynamics
2.3.1 Genomics In Cancer Care Industry Trends
2.3.2 Genomics In Cancer Care Market Drivers
2.3.3 Genomics In Cancer Care Market Challenges
2.3.4 Genomics In Cancer Care Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genomics In Cancer Care Players by Revenue
3.1.1 Global Top Genomics In Cancer Care Players by Revenue (2018-2023)
3.1.2 Global Genomics In Cancer Care Revenue Market Share by Players (2018-2023)
3.2 Global Genomics In Cancer Care Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genomics In Cancer Care Revenue
3.4 Global Genomics In Cancer Care Market Concentration Ratio
3.4.1 Global Genomics In Cancer Care Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomics In Cancer Care Revenue in 2022
3.5 Genomics In Cancer Care Key Players Head office and Area Served
3.6 Key Players Genomics In Cancer Care Product Solution and Service
3.7 Date of Enter into Genomics In Cancer Care Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genomics In Cancer Care Breakdown Data by Type
4.1 Global Genomics In Cancer Care Historic Market Size by Type (2018-2023)
4.2 Global Genomics In Cancer Care Forecasted Market Size by Type (2024-2033)
5 Genomics In Cancer Care Breakdown Data by Application
5.1 Global Genomics In Cancer Care Historic Market Size by Application (2018-2023)
5.2 Global Genomics In Cancer Care Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Genomics In Cancer Care Market Size (2018-2033)
6.2 North America Genomics In Cancer Care Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Genomics In Cancer Care Market Size by Country (2018-2023)
6.4 North America Genomics In Cancer Care Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genomics In Cancer Care Market Size (2018-2033)
7.2 Europe Genomics In Cancer Care Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Genomics In Cancer Care Market Size by Country (2018-2023)
7.4 Europe Genomics In Cancer Care Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genomics In Cancer Care Market Size (2018-2033)
8.2 Asia-Pacific Genomics In Cancer Care Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Genomics In Cancer Care Market Size by Region (2018-2023)
8.4 Asia-Pacific Genomics In Cancer Care Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genomics In Cancer Care Market Size (2018-2033)
9.2 Latin America Genomics In Cancer Care Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Genomics In Cancer Care Market Size by Country (2018-2023)
9.4 Latin America Genomics In Cancer Care Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genomics In Cancer Care Market Size (2018-2033)
10.2 Middle East & Africa Genomics In Cancer Care Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Genomics In Cancer Care Market Size by Country (2018-2023)
10.4 Middle East & Africa Genomics In Cancer Care Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Genomics In Cancer Care Introduction
11.1.4 Illumina Revenue in Genomics In Cancer Care Business (2018-2023)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher scientific
11.2.1 Thermo Fisher scientific Company Detail
11.2.2 Thermo Fisher scientific Business Overview
11.2.3 Thermo Fisher scientific Genomics In Cancer Care Introduction
11.2.4 Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2018-2023)
11.2.5 Thermo Fisher scientific Recent Development
11.3 Agilent
11.3.1 Agilent Company Detail
11.3.2 Agilent Business Overview
11.3.3 Agilent Genomics In Cancer Care Introduction
11.3.4 Agilent Revenue in Genomics In Cancer Care Business (2018-2023)
11.3.5 Agilent Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Genomics In Cancer Care Introduction
11.4.4 Roche Revenue in Genomics In Cancer Care Business (2018-2023)
11.4.5 Roche Recent Development
11.5 Cancer Genetics
11.5.1 Cancer Genetics Company Detail
11.5.2 Cancer Genetics Business Overview
11.5.3 Cancer Genetics Genomics In Cancer Care Introduction
11.5.4 Cancer Genetics Revenue in Genomics In Cancer Care Business (2018-2023)
11.5.5 Cancer Genetics Recent Development
11.6 Beckman Coulter
11.6.1 Beckman Coulter Company Detail
11.6.2 Beckman Coulter Business Overview
11.6.3 Beckman Coulter Genomics In Cancer Care Introduction
11.6.4 Beckman Coulter Revenue in Genomics In Cancer Care Business (2018-2023)
11.6.5 Beckman Coulter Recent Development
11.7 Bio-Rad
11.7.1 Bio-Rad Company Detail
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad Genomics In Cancer Care Introduction
11.7.4 Bio-Rad Revenue in Genomics In Cancer Care Business (2018-2023)
11.7.5 Bio-Rad Recent Development
11.8 Danaher
11.8.1 Danaher Company Detail
11.8.2 Danaher Business Overview
11.8.3 Danaher Genomics In Cancer Care Introduction
11.8.4 Danaher Revenue in Genomics In Cancer Care Business (2018-2023)
11.8.5 Danaher Recent Development
11.9 Sigma Aldrich
11.9.1 Sigma Aldrich Company Detail
11.9.2 Sigma Aldrich Business Overview
11.9.3 Sigma Aldrich Genomics In Cancer Care Introduction
11.9.4 Sigma Aldrich Revenue in Genomics In Cancer Care Business (2018-2023)
11.9.5 Sigma Aldrich Recent Development
11.10 Pacific Biosciences
11.10.1 Pacific Biosciences Company Detail
11.10.2 Pacific Biosciences Business Overview
11.10.3 Pacific Biosciences Genomics In Cancer Care Introduction
11.10.4 Pacific Biosciences Revenue in Genomics In Cancer Care Business (2018-2023)
11.10.5 Pacific Biosciences Recent Development
11.11 Quest Diagnostics
11.11.1 Quest Diagnostics Company Detail
11.11.2 Quest Diagnostics Business Overview
11.11.3 Quest Diagnostics Genomics In Cancer Care Introduction
11.11.4 Quest Diagnostics Revenue in Genomics In Cancer Care Business (2018-2023)
11.11.5 Quest Diagnostics Recent Development
11.12 Luminex
11.12.1 Luminex Company Detail
11.12.2 Luminex Business Overview
11.12.3 Luminex Genomics In Cancer Care Introduction
11.12.4 Luminex Revenue in Genomics In Cancer Care Business (2018-2023)
11.12.5 Luminex Recent Development
11.13 Oxford Gene Technology
11.13.1 Oxford Gene Technology Company Detail
11.13.2 Oxford Gene Technology Business Overview
11.13.3 Oxford Gene Technology Genomics In Cancer Care Introduction
11.13.4 Oxford Gene Technology Revenue in Genomics In Cancer Care Business (2018-2023)
11.13.5 Oxford Gene Technology Recent Development
11.14 PerkinElmer
11.14.1 PerkinElmer Company Detail
11.14.2 PerkinElmer Business Overview
11.14.3 PerkinElmer Genomics In Cancer Care Introduction
11.14.4 PerkinElmer Revenue in Genomics In Cancer Care Business (2018-2023)
11.14.5 PerkinElmer Recent Development
11.15 Qiagen
11.15.1 Qiagen Company Detail
11.15.2 Qiagen Business Overview
11.15.3 Qiagen Genomics In Cancer Care Introduction
11.15.4 Qiagen Revenue in Genomics In Cancer Care Business (2018-2023)
11.15.5 Qiagen Recent Development
11.16 GE Healthcare
11.16.1 GE Healthcare Company Detail
11.16.2 GE Healthcare Business Overview
11.16.3 GE Healthcare Genomics In Cancer Care Introduction
11.16.4 GE Healthcare Revenue in Genomics In Cancer Care Business (2018-2023)
11.16.5 GE Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Genomics In Cancer Care Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Instruments
Table 3. Key Players of Consumables
Table 4. Key Players of Services
Table 5. Global Genomics In Cancer Care Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Genomics In Cancer Care Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Genomics In Cancer Care Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Genomics In Cancer Care Market Share by Region (2018-2023)
Table 9. Global Genomics In Cancer Care Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Genomics In Cancer Care Market Share by Region (2024-2033)
Table 11. Genomics In Cancer Care Market Trends
Table 12. Genomics In Cancer Care Market Drivers
Table 13. Genomics In Cancer Care Market Challenges
Table 14. Genomics In Cancer Care Market Restraints
Table 15. Global Genomics In Cancer Care Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Genomics In Cancer Care Market Share by Players (2018-2023)
Table 17. Global Top Genomics In Cancer Care Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomics In Cancer Care as of 2022)
Table 18. Ranking of Global Top Genomics In Cancer Care Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Genomics In Cancer Care Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Genomics In Cancer Care Product Solution and Service
Table 22. Date of Enter into Genomics In Cancer Care Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Genomics In Cancer Care Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Genomics In Cancer Care Revenue Market Share by Type (2018-2023)
Table 26. Global Genomics In Cancer Care Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Genomics In Cancer Care Revenue Market Share by Type (2024-2033)
Table 28. Global Genomics In Cancer Care Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Genomics In Cancer Care Revenue Market Share by Application (2018-2023)
Table 30. Global Genomics In Cancer Care Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Genomics In Cancer Care Revenue Market Share by Application (2024-2033)
Table 32. North America Genomics In Cancer Care Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Genomics In Cancer Care Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Genomics In Cancer Care Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Genomics In Cancer Care Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Genomics In Cancer Care Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Genomics In Cancer Care Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Genomics In Cancer Care Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Genomics In Cancer Care Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Genomics In Cancer Care Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Genomics In Cancer Care Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Genomics In Cancer Care Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Genomics In Cancer Care Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Genomics In Cancer Care Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Genomics In Cancer Care Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Genomics In Cancer Care Market Size by Country (2024-2033) & (US$ Million)
Table 47. Illumina Company Detail
Table 48. Illumina Business Overview
Table 49. Illumina Genomics In Cancer Care Product
Table 50. Illumina Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 51. Illumina Recent Development
Table 52. Thermo Fisher scientific Company Detail
Table 53. Thermo Fisher scientific Business Overview
Table 54. Thermo Fisher scientific Genomics In Cancer Care Product
Table 55. Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 56. Thermo Fisher scientific Recent Development
Table 57. Agilent Company Detail
Table 58. Agilent Business Overview
Table 59. Agilent Genomics In Cancer Care Product
Table 60. Agilent Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 61. Agilent Recent Development
Table 62. Roche Company Detail
Table 63. Roche Business Overview
Table 64. Roche Genomics In Cancer Care Product
Table 65. Roche Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Cancer Genetics Company Detail
Table 68. Cancer Genetics Business Overview
Table 69. Cancer Genetics Genomics In Cancer Care Product
Table 70. Cancer Genetics Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 71. Cancer Genetics Recent Development
Table 72. Beckman Coulter Company Detail
Table 73. Beckman Coulter Business Overview
Table 74. Beckman Coulter Genomics In Cancer Care Product
Table 75. Beckman Coulter Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 76. Beckman Coulter Recent Development
Table 77. Bio-Rad Company Detail
Table 78. Bio-Rad Business Overview
Table 79. Bio-Rad Genomics In Cancer Care Product
Table 80. Bio-Rad Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 81. Bio-Rad Recent Development
Table 82. Danaher Company Detail
Table 83. Danaher Business Overview
Table 84. Danaher Genomics In Cancer Care Product
Table 85. Danaher Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 86. Danaher Recent Development
Table 87. Sigma Aldrich Company Detail
Table 88. Sigma Aldrich Business Overview
Table 89. Sigma Aldrich Genomics In Cancer Care Product
Table 90. Sigma Aldrich Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 91. Sigma Aldrich Recent Development
Table 92. Pacific Biosciences Company Detail
Table 93. Pacific Biosciences Business Overview
Table 94. Pacific Biosciences Genomics In Cancer Care Product
Table 95. Pacific Biosciences Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 96. Pacific Biosciences Recent Development
Table 97. Quest Diagnostics Company Detail
Table 98. Quest Diagnostics Business Overview
Table 99. Quest Diagnostics Genomics In Cancer Care Product
Table 100. Quest Diagnostics Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 101. Quest Diagnostics Recent Development
Table 102. Luminex Company Detail
Table 103. Luminex Business Overview
Table 104. Luminex Genomics In Cancer Care Product
Table 105. Luminex Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 106. Luminex Recent Development
Table 107. Oxford Gene Technology Company Detail
Table 108. Oxford Gene Technology Business Overview
Table 109. Oxford Gene Technology Genomics In Cancer Care Product
Table 110. Oxford Gene Technology Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 111. Oxford Gene Technology Recent Development
Table 112. PerkinElmer Company Detail
Table 113. PerkinElmer Business Overview
Table 114. PerkinElmer Genomics In Cancer Care Product
Table 115. PerkinElmer Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 116. PerkinElmer Recent Development
Table 117. Qiagen Company Detail
Table 118. Qiagen Business Overview
Table 119. Qiagen Genomics In Cancer Care Product
Table 120. Qiagen Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 121. Qiagen Recent Development
Table 122. GE Healthcare Company Detail
Table 123. GE Healthcare Business Overview
Table 124. GE Healthcare Genomics In Cancer Care Product
Table 125. GE Healthcare Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 126. GE Healthcare Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genomics In Cancer Care Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Genomics In Cancer Care Market Share by Type: 2022 VS 2033
Figure 3. Instruments Features
Figure 4. Consumables Features
Figure 5. Services Features
Figure 6. Global Genomics In Cancer Care Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Genomics In Cancer Care Market Share by Application: 2022 VS 2033
Figure 8. Diagnostics Case Studies
Figure 9. Personalized Medicine Case Studies
Figure 10. Drug Discovery Case Studies
Figure 11. Development Case Studies
Figure 12. Research Case Studies
Figure 13. Genomics In Cancer Care Report Years Considered
Figure 14. Global Genomics In Cancer Care Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Genomics In Cancer Care Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Genomics In Cancer Care Market Share by Region: 2022 VS 2033
Figure 17. Global Genomics In Cancer Care Market Share by Players in 2022
Figure 18. Global Top Genomics In Cancer Care Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomics In Cancer Care as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Genomics In Cancer Care Revenue in 2022
Figure 20. North America Genomics In Cancer Care Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Genomics In Cancer Care Market Share by Country (2018-2033)
Figure 22. United States Genomics In Cancer Care Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Genomics In Cancer Care Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Genomics In Cancer Care Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Genomics In Cancer Care Market Share by Country (2018-2033)
Figure 26. Germany Genomics In Cancer Care Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Genomics In Cancer Care Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Genomics In Cancer Care Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Genomics In Cancer Care Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Genomics In Cancer Care Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Genomics In Cancer Care Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Genomics In Cancer Care Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Genomics In Cancer Care Market Share by Region (2018-2033)
Figure 34. China Genomics In Cancer Care Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Genomics In Cancer Care Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Genomics In Cancer Care Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Genomics In Cancer Care Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Genomics In Cancer Care Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Genomics In Cancer Care Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Genomics In Cancer Care Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Genomics In Cancer Care Market Share by Country (2018-2033)
Figure 42. Mexico Genomics In Cancer Care Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Genomics In Cancer Care Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Genomics In Cancer Care Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Genomics In Cancer Care Market Share by Country (2018-2033)
Figure 46. Turkey Genomics In Cancer Care Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Genomics In Cancer Care Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Illumina Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 49. Thermo Fisher scientific Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 50. Agilent Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 51. Roche Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 52. Cancer Genetics Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 53. Beckman Coulter Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 54. Bio-Rad Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 55. Danaher Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 56. Sigma Aldrich Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 57. Pacific Biosciences Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 58. Quest Diagnostics Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 59. Luminex Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 60. Oxford Gene Technology Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 61. PerkinElmer Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 62. Qiagen Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 63. GE Healthcare Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed